US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 0.575
  • -0.028-4.60%
Close Jul 3 13:00 ET
8.50MMarket Cap-687P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
32.01%1.77M
20.97%8.53M
126.78%3.06M
74.75%3.16M
-59.92%970.22K
-8.96%1.34M
227.48%7.05M
1.35M
1.81M
2.42M
Selling and administrative expenses
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
--736.06K
--1.59M
-General and administrative expense
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
--736.06K
--1.59M
Research and development costs
180.66%762.28K
-33.11%1.57M
-56.25%387.12K
42.00%1.02M
-137.50%-101.02K
-43.30%271.61K
243.56%2.35M
--884.76K
--714.97K
--269.39K
Other operating expenses
----
-73.39%453.55K
--0
----
----
20.98%453.55K
144.32%1.7M
--411.3K
--357.35K
--560.8K
Operating profit
-32.01%-1.77M
-20.97%-8.53M
-126.78%-3.06M
-74.75%-3.16M
59.92%-970.22K
8.96%-1.34M
-227.48%-7.05M
-1.35M
-1.81M
-2.42M
Net non-operating interest income expense
3,149.97%50.42K
-33,619.94%-3.46M
-154,544.45%-2.73M
-18,440.62%-427.73K
-12,681.30%-295.89K
57.20%-1.65K
57.95%-10.25K
-1.77K
-2.31K
-2.32K
Non-operating interest expense
----
33,619.94%3.46M
154,544.45%2.73M
18,440.62%427.73K
12,681.30%295.89K
----
-57.95%10.25K
--1.77K
--2.31K
--2.32K
Total other finance cost
-3,149.97%-50.42K
----
----
----
----
--1.65K
----
----
----
----
Other net income (expense)
Income before tax
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
-2.42M
Income tax
Net income
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
-2.42M
Net income continuous Operations
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
---1.35M
---1.81M
---2.42M
Minority interest income
Net income attributable to the parent company
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
-2.42M
Basic earnings per share
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
-0.102
-0.1365
Diluted earnings per share
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
-0.102
-0.1365
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 32.01%1.77M20.97%8.53M126.78%3.06M74.75%3.16M-59.92%970.22K-8.96%1.34M227.48%7.05M1.35M1.81M2.42M
Selling and administrative expenses 63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K--736.06K--1.59M
-General and administrative expense 63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K--736.06K--1.59M
Research and development costs 180.66%762.28K-33.11%1.57M-56.25%387.12K42.00%1.02M-137.50%-101.02K-43.30%271.61K243.56%2.35M--884.76K--714.97K--269.39K
Other operating expenses -----73.39%453.55K--0--------20.98%453.55K144.32%1.7M--411.3K--357.35K--560.8K
Operating profit -32.01%-1.77M-20.97%-8.53M-126.78%-3.06M-74.75%-3.16M59.92%-970.22K8.96%-1.34M-227.48%-7.05M-1.35M-1.81M-2.42M
Net non-operating interest income expense 3,149.97%50.42K-33,619.94%-3.46M-154,544.45%-2.73M-18,440.62%-427.73K-12,681.30%-295.89K57.20%-1.65K57.95%-10.25K-1.77K-2.31K-2.32K
Non-operating interest expense ----33,619.94%3.46M154,544.45%2.73M18,440.62%427.73K12,681.30%295.89K-----57.95%10.25K--1.77K--2.31K--2.32K
Total other finance cost -3,149.97%-50.42K------------------1.65K----------------
Other net income (expense)
Income before tax -28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M-2.42M
Income tax
Net income -28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M-2.42M
Net income continuous Operations -28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M---1.35M---1.81M---2.42M
Minority interest income
Net income attributable to the parent company -28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M-2.42M
Basic earnings per share -20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076-0.102-0.1365
Diluted earnings per share -20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076-0.102-0.1365
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg